Literature DB >> 23924352

Inhibition of Cronobacter sakazakii by heat labile bacteriocins produced by probiotic LAB isolated from healthy infants.

Saddam S Awaisheh1, Anas A Al-Nabulsi, Tareq M Osaili, Salam Ibrahim, Richard Holley.   

Abstract

Cronobacter sakazakii is an opportunistic pathogen that can cause bacteremia, meningitis, and necrotizing enterocolitis, most often in neonates with case-fatality rates that may reach 80%. The antimicrobial activity of lactic acid bacteria against a wide range of foodborne pathogens is well-established in different types of food products. The objective of the current study was to investigate the antibacterial activity of Lactobacillus acidophilus and L. casei isolated from feces of healthy infants against different strains of C. sakazakii in agar and a rehydrated infant milk formula (RIMF) model. The inhibition zones of C. sakazakii around L. acidophilus or L. casei ranged from 22 to 32 mm on eMan Rogosa Sharpe (MRS) agar under aerobic conditions, while a slight reduction in antibacterial activity was noted on modified MRS (0.2% glucose) under anaerobic conditions. It was observed that pH-neutralized cell-free supernatant (CFS) of L. acidophilus or L. casei was inhibitory against tested C. sakazakii strains. The inhibition zones of neutralized CFS were lower than the antibacterial activities of live cultures. The antibacterial activity of CFS was abolished when CFS from L. acidophilus or L. casei was heated at 60 or 80 °C for either 10 min or 2 h, or treated with trypsin or pepsin. This was considered strong evidence that the inhibition was due to the production of bacteriocins by L. casei and L. acidophilus. Both the CFS and active growing cells of L. casei and L. acidophilus were able to reduce the viability of C. sakazakii in the RIMF model. The results may extend the use of natural antimicrobials instead of conventional preservation methods to improve the safety of RIMF.
© 2013 Institute of Food Technologists®

Entities:  

Keywords:  C. sakazakii; LAB; antibacterial activity; bacteriocins; food safety; infant food

Mesh:

Substances:

Year:  2013        PMID: 23924352     DOI: 10.1111/1750-3841.12209

Source DB:  PubMed          Journal:  J Food Sci        ISSN: 0022-1147            Impact factor:   3.167


  16 in total

1.  Impairment of Cronobacter sakazakii and Listeria monocytogenes biofilms by cell-free preparations of lactobacilli of goat milk origin.

Authors:  Niharika Singh; Ravinder Kaur; Brij Pal Singh; Namita Rokana; Gunjan Goel; Anil Kumar Puniya; Harsh Panwar
Journal:  Folia Microbiol (Praha)       Date:  2019-06-19       Impact factor: 2.099

2.  Lactobacillus spp. inhibit the growth of Cronobacter sakazakii ATCC 29544 by altering its membrane integrity.

Authors:  Raffaella Campana; Sara Federici; Eleonora Ciandrini; Anita Manti; Wally Baffone
Journal:  J Food Sci Technol       Date:  2019-07-11       Impact factor: 2.701

Review 3.  Impact of probiotics on necrotizing enterocolitis.

Authors:  Mark A Underwood
Journal:  Semin Perinatol       Date:  2016-11-08       Impact factor: 3.300

4.  Probiotics and Innate and Adaptive Immune Responses in Premature Infants.

Authors:  Mark A Underwood
Journal:  For Immunopathol Dis Therap       Date:  2016

5.  Sil: a Streptococcus iniae bacteriocin with dual role as an antimicrobial and an immunomodulator that inhibits innate immune response and promotes S. iniae infection.

Authors:  Mo-fei Li; Bao-cun Zhang; Jun Li; Li Sun
Journal:  PLoS One       Date:  2014-04-29       Impact factor: 3.240

Review 6.  Novel approaches to improve the intrinsic microbiological safety of powdered infant milk formula.

Authors:  Robert M Kent; Gerald F Fitzgerald; Colin Hill; Catherine Stanton; R Paul Ross
Journal:  Nutrients       Date:  2015-02-12       Impact factor: 5.717

7.  Inhibition of Cronobacter sakazakii by Lactobacillus acidophilus n.v. Er2 317/402.

Authors:  Haykuhi Charchoghlyan; Heejun Kwon; Dong-Ju Hwang; Jong Suk Lee; Junsoo Lee; Myunghee Kim
Journal:  Korean J Food Sci Anim Resour       Date:  2016-10-31       Impact factor: 2.622

Review 8.  Luminal Conversion and Immunoregulation by Probiotics.

Authors:  Bhanu Priya Ganesh; James Versalovic
Journal:  Front Pharmacol       Date:  2015-11-12       Impact factor: 5.810

9.  Colonization with Escherichia coli EC 25 protects neonatal rats from necrotizing enterocolitis.

Authors:  Debi M Thomas; Brandon Bell; Stephanie Papillon; Patrick Delaplain; Joanna Lim; Jamie Golden; Jordan Bowling; Jin Wang; Larry Wang; Anatoly V Grishin; Henri R Ford
Journal:  PLoS One       Date:  2017-11-30       Impact factor: 3.240

10.  Efficacy of (+)-Lariciresinol to Control Bacterial Growth of Staphylococcus aureus and Escherichia coli O157:H7.

Authors:  Vivek K Bajpai; Shruti Shukla; Woon K Paek; Jeongheui Lim; Pradeep Kumar; Pankaj Kumar; MinKyun Na
Journal:  Front Microbiol       Date:  2017-05-03       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.